Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg

NCT01929512 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: HCP1201 750/20mg
DRUG: Metformin SR 750mg
DRUG: Rosuvastatin 20mg

Sponsor

Hanmi Pharmaceutical Company Limited